Fundraising FoxPic Therapeutics
Boston, US · Founded 2016 · Delaware corporation · 3 known investors
Find your way into Pic Therapeutics
Sign up to see every warm intro you have to Pic Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pic Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DR
Dr. Richard PetersNamed on SEC filing
BT
Belinda TermeerNamed on SEC filing
DA
DG
Dr. Gerhard WagnerNamed on SEC filing
SA
Investors · 3
Advent Life Scienceslisted by Advent Life SciencesLondon
How we know: a partner's Signal profile · Not right? Tell us
Lumira VenturesinferredToronto · $1M – $10Mvia Gerry Brunk · board
How we know: board seat on SEC Form D · Not right? Tell us
OrbiMedreportedNew York · $1M – $75M
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19.6M disclosed across 3 rounds · 2020–2022
▶$6.5MraisedOct 2022 · 22 investors · BiotechnologyRule 506(b)
▶$6.5MraisedOct 2022 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gerry BrunkDirector
- Tal Zaks, MD, PhDDirector
- Belinda TermeerDirector
- Dr. Alan E. WaltsDirector
- Dr. Katherine S. BowdishExecutive Officer, Director
- Dr. Gerhard WagnerDirector
- Offering amount
- $35M
- Amount sold
- $6.5M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedAug 2022 · 17 investors · BiotechnologyRule 506(b)
▶$1.7MraisedAug 2022 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dr. Gerhard WagnerDirector
- Dr. Alan E. WaltsDirector
- Dr. Katherine S. BowdishExecutive Officer, Director
- Belinda TermeerDirector
- Offering amount
- $6M
- Amount sold
- $1.7M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.5MraisedApr 2020 · 36 investors · BiotechnologyRule 506(b)
▶$11.5MraisedApr 2020 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dr. Richard PetersDirector
- Belinda TermeerDirector
- Dr. Alan E. WaltsDirector
- Dr. Gerhard WagnerDirector
- Sun AltbachExecutive Officer, Director
- Offering amount
- $11.5M
- Amount sold
- $11.5M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Pic Therapeutics's investors?
- Pic Therapeutics's investors include Advent Life Sciences, Lumira Ventures, OrbiMed.
- How much funding has Pic Therapeutics raised?
- Pic Therapeutics has disclosed $19.6M raised across 3 rounds.
- Where is Pic Therapeutics headquartered?
- Pic Therapeutics is headquartered in Boston, US.